We also analyzed ERO1A expression in breast cancer and normal counterpart tissues from The Cancer Genome Atlas (TCGA) databank and found higher ERO1A levels in the more aggressive basal breast cancer subtype, including TNBC [15, 23]. Here, ERO1A is linked to breast carcinoma.